Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 11 studies | 27% ± 13% | |
endothelial cell | 10 studies | 25% ± 8% | |
fibroblast | 9 studies | 30% ± 16% | |
microglial cell | 7 studies | 24% ± 5% | |
adipocyte | 7 studies | 23% ± 6% | |
myeloid cell | 6 studies | 19% ± 5% | |
epithelial cell | 5 studies | 25% ± 4% | |
astrocyte | 5 studies | 29% ± 9% | |
ciliated cell | 4 studies | 19% ± 2% | |
glutamatergic neuron | 4 studies | 39% ± 15% | |
oligodendrocyte precursor cell | 4 studies | 21% ± 5% | |
endothelial cell of lymphatic vessel | 4 studies | 21% ± 3% | |
mesothelial cell | 3 studies | 20% ± 4% | |
GABAergic neuron | 3 studies | 41% ± 5% | |
club cell | 3 studies | 16% ± 0% | |
monocyte | 3 studies | 20% ± 3% | |
pericyte | 3 studies | 21% ± 7% | |
lymphocyte | 3 studies | 18% ± 2% | |
smooth muscle cell | 3 studies | 17% ± 3% | |
oligodendrocyte | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3746.09 | 89 / 89 | 100% | 34.55 | 901 / 901 |
liver | 100% | 4321.74 | 226 / 226 | 100% | 20.22 | 406 / 406 |
thymus | 100% | 8888.04 | 653 / 653 | 100% | 57.94 | 605 / 605 |
breast | 100% | 5400.10 | 459 / 459 | 100% | 48.25 | 1116 / 1118 |
prostate | 100% | 5636.81 | 245 / 245 | 100% | 38.17 | 501 / 502 |
lung | 100% | 4991.79 | 577 / 578 | 100% | 29.76 | 1153 / 1155 |
uterus | 100% | 5275.93 | 170 / 170 | 100% | 28.53 | 457 / 459 |
skin | 100% | 6372.64 | 1809 / 1809 | 99% | 26.29 | 469 / 472 |
intestine | 100% | 4712.79 | 965 / 966 | 99% | 22.18 | 524 / 527 |
ovary | 100% | 4817.61 | 180 / 180 | 99% | 26.78 | 427 / 430 |
esophagus | 100% | 5436.60 | 1442 / 1445 | 99% | 19.82 | 182 / 183 |
bladder | 100% | 3863.67 | 21 / 21 | 99% | 24.54 | 500 / 504 |
brain | 99% | 2398.74 | 2609 / 2642 | 100% | 36.31 | 705 / 705 |
adrenal gland | 100% | 8054.62 | 258 / 258 | 99% | 29.84 | 227 / 230 |
stomach | 100% | 4203.95 | 358 / 359 | 99% | 22.39 | 283 / 286 |
pancreas | 90% | 1540.90 | 295 / 328 | 99% | 40.52 | 176 / 178 |
adipose | 100% | 6194.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.50 | 29 / 29 |
spleen | 100% | 4255.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.33 | 1 / 1 |
blood vessel | 100% | 6336.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 6301.43 | 802 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 30.85 | 79 / 80 |
heart | 98% | 2974.30 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 79% | 2962.15 | 738 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0038160 | Biological process | CXCL12-activated CXCR4 signaling pathway |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0030097 | Biological process | hemopoiesis |
GO_0016020 | Cellular component | membrane |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | WBP1L |
Protein name | WW domain binding protein 1-like (Outcome predictor in acute leukemia 1) WW domain binding protein 1 like |
Synonyms | OPA1L C10orf26 |
Description | |
Accessions | ENST00000369889.5 [Q9NX94-1] ENST00000647664.1 ENST00000448841.7 [Q9NX94-2] Q9NX94 A0A3B3IU90 |